NCT04635748

Brief Summary

This project will investigate how review of collateral information sources (CIS) may impact clinical decision-making across the lifespan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
89

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 3, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 19, 2020

Completed
Last Updated

October 26, 2021

Status Verified

October 1, 2021

Enrollment Period

3 months

First QC Date

November 13, 2020

Last Update Submit

October 18, 2021

Conditions

Depressive DisorderAnxiety Disorders

Outcome Measures

Primary Outcomes (1)

  • McLean Treatment Tracking Survey

    Clinicians will find the McLean Treatment Tracking Survey easy to use in their clinical care and we will measure rate of use and completion.

    Over the course of 1 week

Secondary Outcomes (1)

  • Clinical Outcome - Increased treatment decisions made

    Over the course of 1 week

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

\- Clinicians from McLean Hospital Outpatient Programs (geriatric, child and adult) and the McLean Behavioral Health Partial Program, which predominantly treat patients with mood disorders.

You may qualify if:

  • Credentialed to provide psychopharmacology or psychotherapy at McLean and Licensed by the State of Massachusetts
  • Practice pharmacotherapy and either adjunctive or stand-alone evidence-based psychotherapy (e.g., CBT, DBT, supportive psychotherapy, etc.)
  • Fluent in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McLean Hospital

Belmont, Massachusetts, 02478, United States

Location

MeSH Terms

Conditions

Depressive DisorderAnxiety Disorders

Condition Hierarchy (Ancestors)

Mood DisordersMental Disorders

Study Officials

  • Ipsit V Vahia, MD

    Mclean Hospital

    PRINCIPAL INVESTIGATOR

  • Kerry J Ressler, MD; PhD

    Mclean Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director, Geriatric Psychiatry Outpatient Services

Study Record Dates

First Submitted

November 13, 2020

First Posted

November 19, 2020

Study Start

December 3, 2019

Primary Completion

March 14, 2020

Study Completion

March 14, 2020

Last Updated

October 26, 2021

Record last verified: 2021-10

Locations

US(1)